Found: 27
Select item for more details and to access through your institution.
Acute gastrointestinal bleeding: proposed study outcomes for new randomised controlled trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 616, doi. 10.1111/apt.16483
- By:
- Publication type:
- Article
Letter: mind the gap—search and publication date of systematic reviews and meta‐analysis. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 733, doi. 10.1111/apt.16542
- By:
- Publication type:
- Article
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 709, doi. 10.1111/apt.16538
- By:
- Publication type:
- Article
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti‐viral therapy—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 724, doi. 10.1111/apt.16548
- By:
- Publication type:
- Article
Editorial: acute gastrointestinal bleeding—proposed new study outcomes. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 717, doi. 10.1111/apt.16545
- By:
- Publication type:
- Article
Letter: mind the gap – search and publication date of systematic reviews and meta‐analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 730, doi. 10.1111/apt.16537
- By:
- Publication type:
- Article
Editorial: does anti‐TNF 'treatment persistence' always equate to 'effective treatment'? Only objective disease assessments can answer the question. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 720, doi. 10.1111/apt.16535
- By:
- Publication type:
- Article
Editorial: when to start carvedilol in cirrhosis—time to reconsider? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 728, doi. 10.1111/apt.16526
- By:
- Publication type:
- Article
Letter: Hepatitis B and MAFLD ‐ a consilience of risk factors for hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 736, doi. 10.1111/apt.16532
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: effects of implementing a nutrition support team for in‐hospital parenteral nutrition.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 560, doi. 10.1111/apt.16530
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: neoplasia detection rate and post‐endoscopy Barrett's neoplasia in Barrett's oesophagus.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 546, doi. 10.1111/apt.16531
- By:
- Publication type:
- Article
PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 699, doi. 10.1111/apt.16513
- By:
- Publication type:
- Article
Letter: missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease—still significant room for improvement.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 734, doi. 10.1111/apt.16521
- By:
- Publication type:
- Article
Editorial: acute gastrointestinal bleeding – proposed new study outcomes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 715, doi. 10.1111/apt.16517
- By:
- Publication type:
- Article
Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population‐based study of 1322 Australians.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 627, doi. 10.1111/apt.16500
- By:
- Publication type:
- Article
Systematic review: hepatitis C viraemic allografts to hepatitis C‐negative recipients in solid organ transplantation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 571, doi. 10.1111/apt.16508
- By:
- Publication type:
- Article
Editorial: when to start carvedilol in cirrhosis—time to reconsider?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 726, doi. 10.1111/apt.16512
- By:
- Publication type:
- Article
Editorial: does anti‐TNF "treatment persistence" always equate to "effective treatment"? Only objective disease assessments can answer the question.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 718, doi. 10.1111/apt.16506
- By:
- Publication type:
- Article
Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 689, doi. 10.1111/apt.16488
- By:
- Publication type:
- Article
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 678, doi. 10.1111/apt.16497
- By:
- Publication type:
- Article
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti‐viral therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 722, doi. 10.1111/apt.16498
- By:
- Publication type:
- Article
Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 667, doi. 10.1111/apt.16478
- By:
- Publication type:
- Article
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 606, doi. 10.1111/apt.16464
- By:
- Publication type:
- Article
Effect of point‐of‐care gastrointestinal ultrasound on decision‐making and management in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 652, doi. 10.1111/apt.16452
- By:
- Publication type:
- Article
Comorbidity before and after a diagnosis of inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 637, doi. 10.1111/apt.16444
- By:
- Publication type:
- Article
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 583, doi. 10.1111/apt.16374
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 543, doi. 10.1111/apt.15854
- Publication type:
- Article